According to this recent study, pembrolizumab as adjuvant therapy for up to approximately 1 year for stage IIB or IIC melanoma resulted in a significant reduction in the risk of disease recurrence or death versus placebo, with a manageable safety profile.
According to this recent study, the melanoma-specific survival rates in the two Central Malignant Melanoma Registry (CMMR) cohorts across stages I and II are less favorable than published in American Joint Committee on Cancer version 8. This has important implications for the consideration of adjuvant treatment in this population.
According to this recent study, findings provide a strong rationale for randomized clinical trials testing response-directed treatment personalization after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma.
This recent study’s findings highlight the potential role of Instagram as a platform for improving awareness of skin cancer risks and the benefits of prevention practices. Authors believe that social media is the most promising venue for researchers and dermatologists to dedicate their efforts and presence that can widely reach the public to educate about skin cancer and empower prevention.
According to this recent study, discussion of risks and benefits of adjuvant therapy is warranted because there should be less tolerance for substantial toxicity in the adjuvant setting. Adjuvant trials are needed that will integrate biomarkers to allow for better selection of patients who will truly benefit from adjuvant therapy.
According to this recent study, prognostic and predictive biomarkers, as well as strategies to reduce treatment-related toxicities and overcome resistance, are required and are now the focus of clinical and translational research in advanced melanoma treatment.
The Auckland Medical Research Foundation is calling for applications for the JI Sutherland Medical Research Fellowship. This Fellowship is open to medical or science graduates with New Zealand residency, permanent residency or citizenship who wish to undertake full-time medical research for a PhD or an MD in the specific field of melanoma or other skin cancer research. Applications must be received through the AMRF portal by 5.00 pm, 3 August 2022.
According to this recent study, worldwide consensus guidelines consistently recommend up-front combination immunotherapies or targeted therapies with or without stereotactic radiosurgery for the treatment of melanoma brain metastases.
Authors of this recent study performed a comprehensive web search of current tanning bed legislation for minors on the three continents North America, Australia, and Europe, and found a wide variety of different legislations. The study concludes that the comparison is an important starting point for institutions such as the World Health Organization or the European Commission to advance their goals towards a harmonization of tanning bed legislation in general and for minors in particular.
The aim of this recent study was to determine the point prevalence of pre-skin cancer (actinic keratosis (PSC)), non-melanoma (NMSC) and melanoma skin cancers (MSC) in Australian surfers and swimmers. The study concludes that point prevalence of MSC (groups combined) was 76-fold higher than the general Australian population. These findings highlight the clinical importance of regular skin cancer screenings in individuals who surf or swim for early detection and treatment of skin cancer.